耐黏菌素革兰阴性杆菌及肺炎克雷伯菌感染的危险因素分析
该研究回顾性分析了2011至2016年间一家大型学术医院系统中28,512株革兰阴性杆菌(含4,557株肺炎克雷伯菌),其中128株为耐黏菌素(MIC>2 μg/ml),包括68株耐黏菌素肺炎克雷伯菌。多因素分析确定了耐黏菌素革兰阴性杆菌和耐黏菌素肺炎克雷伯菌各自的危险因素,并据此建立了可用于指导经验性抗菌治疗的评分系统。
要点
- 耐黏菌素革兰阴性杆菌的危险因素包括神经系统疾病、入住养老院、90天内使用碳青霉烯类等。
- 耐黏菌素肺炎克雷伯菌的危险因素还包括90天内使用抗MRSA药物。
- 基于危险因素建立的评分系统可辅助临床经验性抗菌治疗决策。
核心结论
- 耐黏菌素革兰阴性杆菌和耐黏菌素肺炎克雷伯菌感染相关死亡率高且治疗选择有限,识别危险因素有助于指导经验性治疗。
研究设计与样本
- 回顾性分析2011至2016年一家大型学术医院系统的28,512株革兰阴性杆菌(包括4,557株肺炎克雷伯菌),其中128株为耐黏菌素(MIC>2 μg/ml),包括68株耐黏菌素肺炎克雷伯菌。
主要发现
- 多因素分析显示耐黏菌素革兰阴性杆菌的危险因素为神经系统疾病、入院前入住养老院、90天内使用碳青霉烯类、既往感染碳青霉烯耐药菌和接受呼吸机支持(c-statistic=0.81)。
- 耐黏菌素肺炎克雷伯菌的危险因素为神经系统疾病、入院前入住养老院、90天内使用碳青霉烯类、90天内使用抗MRSA药物和既往感染碳青霉烯耐药菌(c-statistic=0.89)。
关键数值与推荐
- 耐黏菌素定义为MIC>2 μg/ml。
- 耐黏菌素革兰阴性杆菌模型的c-statistic为0.81,耐黏菌素肺炎克雷伯菌模型为0.89。
临床怎么用
- 临床医生可应用基于这些模型衍生的评分系统,对疑似耐黏菌素革兰阴性杆菌或耐黏菌素肺炎克雷伯菌感染的患者进行经验性抗菌治疗指导。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Infections due to colistin-resistant (Colr) Gram-negative rods (GNRs) and colistin-resistant Klebsiella pneumoniae isolates in particular result in high associated mortality and poor treatment options. To determine the risk factors for recovery on culture of Colr GNRs and ColrK. pneumoniae, analyses were chosen to aid decisions at two separate time points: the first when only Gram stain results are available without any bacterial species information (corresponding to the Colr GNR model) and the second when organism identification is performed but prior to reporting of antimicrobial susceptibility testing results (corresponding to the ColrK. pneumoniae model). Cases were retrospectively analyzed at a major academic hospital system from 2011 to 2016. After excluding bacteria that were intrinsically resistant to colistin, a total of 28,512 GNR isolates (4,557 K. pneumoniae isolates) were analyzed, 128 of which were Colr (i.e., MIC > 2 μg/ml), including 68 of which that were ColrK. pneumoniae In multivariate analysis, risk factors for Colr GNRs were neurologic disease, residence in a skilled nursing facility prior to admission, receipt of carbapenems in the last 90 days, prior infection with a carbapenem-resistant organism, and receipt of ventilatory support (c-statistic = 0.81). Risk factors for ColrK. pneumoniae specifically were neurologic disease, residence in a skilled nursing facility prior to admission, receipt of carbapenems in the last 90 days, receipt of an anti-methicillin-resistant Staphylococcus aureus antimicrobial in the last 90 days, and prior infection with a carbapenem-resistant organism (c-statistic = 0.89). A scoring system derived from these models can be applied by providers to guide empirical antimicrobial therapy in patients with infections with suspected Colr GNR and ColrK. pneumoniae isolates.
引用
- Richter SE, Miller L, Uslan DZ, et al. Risk Factors for Colistin Resistance among Gram-Negative Rods and Klebsiella pneumoniae Isolates. J Clin Microbiol. 2018. PMID: 29976595. doi:10.1128/JCM.00149-18
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。